Influence of smoking status on the disease-related outcomes of patients with tobacco-associated superficial transitional cell carcinoma of the bladder

Citation
N. Fleshner et al., Influence of smoking status on the disease-related outcomes of patients with tobacco-associated superficial transitional cell carcinoma of the bladder, CANCER, 86(11), 1999, pp. 2337-2345
Citations number
43
Categorie Soggetti
Oncology,"Onconogenesis & Cancer Research
Journal title
CANCER
ISSN journal
0008543X → ACNP
Volume
86
Issue
11
Year of publication
1999
Pages
2337 - 2345
Database
ISI
SICI code
0008-543X(199912)86:11<2337:IOSSOT>2.0.ZU;2-G
Abstract
BACKGROUND. The aim of this study was to assess the influence of tobacco ex posure, at the time of diagnosis, on the disease-related outcomes of patien ts with tobacco-associated superficial transitional cell carcinoma (TCC) of the bladder. METHODS. A retrospective cohort study was performed using the MSKCC Registr y to identify all institutional cases of "noninvasive" TCC (n = 1632) betwe en 1985 and 1995. After employing exclusion criteria, 286 cases of incident tobacco-associated superficial TCC were divided into 3 strata of tobacco e xposure (127 ex-smokers, 51 quitters, and 108 continued smokers) by chart r eview and post hoc questionnaires (n = 82). Measured outcomes included recu rrence free survival and survival free of adverse events (defined a priori as disease progression or other urinary tract TCC). RESULTS. There were no significant differences among ex-smokers, quitters, and continued smokers in terms of stage, grade, tumor size, multifocality, up-front bacillus Calmette-Guerin therapy, or median follow-up. Ex-smokers presented at a later age than individuals who continued to smoke. Post hoc questionnaires and chart reviews were compared in terms of smoking status a t time of diagnosis, and reliability was excellent (kappa = 0.89). Multivar iate analyses revealed diminished recurrence free survival among continued smokers versus quitters or ex-smokers. Univariate analyses revealed diminis hed adverse event free survival among continued smokers versus quitters or ex-smokers. Multivariate models assessing adverse event free survival revea led a similar trend (P = 0.06). CONCLUSIONS. Continued smokers experience worse disease-associated outcomes than patients who quit smoking. Smoking cessation should thus be employed as a tertiary prevention strategy for patients with superficial TCC. [See e ditorial on pages 2192-4, this issue]. (C) 1999 American Cancer Society.